Cholesterol and abdominal fat also decreased in the blueberry-fed animals (Khanal 2012)
Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
People with significant weight to lose For individuals starting at a higher body weight, say 300 pounds or more, the absolute pounds lost with each medication become dramatic
A lot of times, we need them to be combined with diet, exercise, and ongoing medical care, but they are a very hot topic." GLP-1 medications can also be very expensive, sometimes as much as $1,000 per month
Clinical outcomes and tolerability are equivalent to brand products when formulations meet USP specifications